Aromatherapy Market Size to Hit US$ 2.6 Billion by 2026
/
Date04 May 2019
Email Print Friendly Share LOS ANGELES, May 04, 2019 (GLOBE NEWSWIRE) — The global Aromatherapy Market is estimated to grow at CAGR above 9.7% over... Read More →
Duncan Park Announces Approval of Application to Voluntarily Delist from TSX Venture Exchange; May 10, 2019 to be Last Trading Day
/
Date04 May 2019
Email Print Friendly Share TORONTO, May 04, 2019 (GLOBE NEWSWIRE) — Duncan Park Holdings Corporation (the “Company“) (TSXV: DPH) announced today that the TSX Venture... Read More →
Midland States Bancorp, Inc. Declares Quarterly Cash Dividend of $0.2425 Per Share
/
Date04 May 2019
Email Print Friendly Share EFFINGHAM, Ill., May 03, 2019 (GLOBE NEWSWIRE) — Midland States Bancorp, Inc. (NASDAQ: MSBI) announced today that its Board of Directors... Read More →
Navios Maritime Partners L.P. Reports Financial Results for the First Quarter Ended March 31, 2019
/
Date04 May 2019
Email Print Friendly Share $46.8 million revenue $10.5 million net cash from operating activities $22.7 million adjusted EBITDA $73.5 million Term Loan B prepayment post... Read More →
Man Group PLC : Form 8.3 – OneSavings Bank plc
/
Date04 May 2019
Email Print Friendly Share FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of... Read More →
JBS USA Lux S.A. Announces the Closing of its New Senior Secured Term Loan and Offering of $700 Million of Additional Senior Notes
/
Date04 May 2019
Email Print Friendly Share GREELEY, Colo., May 01, 2019 (GLOBE NEWSWIRE) — JBS USA Lux S.A. (“JBS USA”) announced today the closing of its new... Read More →
AB „Klaipėdos nafta“ 2018 m. audituota metinė informacija
/
Date04 May 2019
Email Print Friendly Share AB „Klaipėdos nafta“, kodas 110648893, buveinė registruota adresu Burių g. 19, Klaipėda (toliau – Bendrovė), 2019 m. balandžio 26 d. įvykęs eilinis... Read More →
Athenex 公佈了 Oraxol 對皮膚血管肉瘤的臨床研究中有潛力的早期和完整反應數據
/
Date04 May 2019
Email Print Friendly Share 紐約水牛城, May 05, 2019 (GLOBE NEWSWIRE) — Athenex, Inc. (NASDAQ: ATNX) 一個致力研究、開發且商業化治療癌症和相關疾病的新療法的全球生物製藥公司，今天公佈的初步數據顯示，無法切除的皮膚血管肉瘤患者，就 Oraxol（口服紫杉醇和 Encequidar，也稱為 HM30181A ）單一藥物治療的兩部分研究中的第一部分，有期望性的早期臨床反應。 現時，已有 10 名患者參加了此項臨床研究，該研究正在美國和香港的四個地點進行。首七名患者已接受了至少六星期的治療，這是第一次反應評估的時間點；另外三名患者尚未達到第一個評估時間點。在治療期間，每週會有三天連續使用 Oraxo ，並在那三天內每日使用一次。 所有... Read More →
Red River Bancshares, Inc. Announces Pricing of Initial Public Offering
/
Date04 May 2019
Email Print Friendly Share ALEXANDRIA, La., May 03, 2019 (GLOBE NEWSWIRE) — Red River Bancshares, Inc. (“the Company”), a holding company that operates through its... Read More →